1. Home
  2. IPSC vs FSEA Comparison

IPSC vs FSEA Comparison

Compare IPSC & FSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPSC
  • FSEA
  • Stock Information
  • Founded
  • IPSC 2019
  • FSEA 1890
  • Country
  • IPSC United States
  • FSEA United States
  • Employees
  • IPSC N/A
  • FSEA N/A
  • Industry
  • IPSC Medicinal Chemicals and Botanical Products
  • FSEA Savings Institutions
  • Sector
  • IPSC Health Care
  • FSEA Finance
  • Exchange
  • IPSC Nasdaq
  • FSEA Nasdaq
  • Market Cap
  • IPSC 58.1M
  • FSEA 51.2M
  • IPO Year
  • IPSC 2021
  • FSEA N/A
  • Fundamental
  • Price
  • IPSC $0.48
  • FSEA $11.65
  • Analyst Decision
  • IPSC Strong Buy
  • FSEA
  • Analyst Count
  • IPSC 5
  • FSEA 0
  • Target Price
  • IPSC $4.67
  • FSEA N/A
  • AVG Volume (30 Days)
  • IPSC 480.0K
  • FSEA 7.6K
  • Earning Date
  • IPSC 03-19-2025
  • FSEA 03-21-2025
  • Dividend Yield
  • IPSC N/A
  • FSEA N/A
  • EPS Growth
  • IPSC N/A
  • FSEA N/A
  • EPS
  • IPSC N/A
  • FSEA N/A
  • Revenue
  • IPSC $6,589,000.00
  • FSEA $15,874,000.00
  • Revenue This Year
  • IPSC N/A
  • FSEA N/A
  • Revenue Next Year
  • IPSC N/A
  • FSEA N/A
  • P/E Ratio
  • IPSC N/A
  • FSEA N/A
  • Revenue Growth
  • IPSC 194.81
  • FSEA 70.41
  • 52 Week Low
  • IPSC $0.47
  • FSEA $8.25
  • 52 Week High
  • IPSC $4.43
  • FSEA $11.65
  • Technical
  • Relative Strength Index (RSI)
  • IPSC 26.49
  • FSEA 74.99
  • Support Level
  • IPSC $0.54
  • FSEA $11.32
  • Resistance Level
  • IPSC $0.59
  • FSEA $11.45
  • Average True Range (ATR)
  • IPSC 0.05
  • FSEA 0.14
  • MACD
  • IPSC -0.00
  • FSEA 0.02
  • Stochastic Oscillator
  • IPSC 3.08
  • FSEA 100.00

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.

About FSEA First Seacoast Bancorp Inc.

First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities and bank-owned life insurance.

Share on Social Networks: